FDA
The US Food and Drug Administration (FDA) said on Tuesday that samples of pasteurised milk had tested positive for remnants of the bird flu virus that has infected dairy cows. The agency stressed that the material is inactivated and that the findings “do not represent actual virus that may be a risk to consumers". Officials added that they're continuing to study the issue. “To date, we have seen nothing that would change our assessment that the commercial milk supply is safe,” the FDA said in a statement. The announcement comes nearly a month after an avian influenza virus that has sickened mi...
Euronews (English)
2024年4月19日 発表 国内主要航空会社は4月19日、2024年ゴールデンウィーク期間(4月27...
トラベル Watch
A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA’s most serious recall, the agency announced Monday. Related Article Patients Facing Death Are Opting for a Lifesaving Heart Device — But at What Risk? The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database contains more than 4,500 reports in which the medical device may have caused or contributed to a patient’s death. Read More The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Th...
Kaiser Health News
A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA’s most serious recall, the agency announced Monday. Patients Facing Death Are Opting for a Lifesaving Heart Device — But at What Risk? The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database contains more than 4,500 reports in which the medical device may have caused or contributed to a patient’s death. Read More The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a ...
California Healthline
米テキサス州オースティン、2024年4月10日 /PRNewswire/ -- セント・デービッド・...
PR Newswire
When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database. One member of the FDA advisory committee was linked to hundreds of payments from Abbott totaling almost $200,000, according to a database maintained by the Department of Health and Human Services. Another was connected to 100 payments totaling about $100,000 and conducted research supported by about $50,000 from Abbott. A thi...
Kaiser Health News
When the FDA recently convened a committee of advisers to assess a cardiac device made by Abbott, the agency didn’t disclose that most of them had received payments from the company or conducted research it had funded — information readily available in a federal database. One member of the FDA advisory committee was linked to hundreds of payments from Abbott totaling almost $200,000, according to a database maintained by the Department of Health and Human Services. Another was connected to 100 payments totaling about $100,000 and conducted research supported by about $50,000 from Abbott. A thi...
California Healthline
The pharmaceutical company behind a drug for amyotrophic lateral sclerosis (ALS) said it would start a process to remove it from the US and Canadian markets. Amylyx Pharmaceuticals said the drug for ALS also known as motor neurone disease (MND) or Lou Gehrig's disease would no longer be available for new patients after a trial showed it did not work. "Patients currently on therapy in the US and Canada who, in consultation with their physician, wish to stay on treatment can be transitioned to a free drug [programme]," the company said. Trials showed no difference to placeboEarlier this month, A...
Euronews (English)
フジドリームエアラインズ(FDA)は、航空機のコクピット窓に展張するサンシェードのデザインを一般公募...
FlyTeam
Washington (AFP) - The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage. Wegovy, produced by Danish pharmaceutical giant Novo Nordisk, was approved "to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight," the FDA said in a statement. The FDA's decision could be a game changer for the approximately 70 percent of American adults who it says are either obese or ...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら